Current status of anaplastic thyroid carcinoma

doi:10.5306/wjco.v15.i6.684

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (895)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

642

Sum=674

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=170

Jun 24, 2024 (publication date) through Nov 29, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Clin Oncol. Jun 24, 2024; 15(6): 684-686
Published online Jun 24, 2024. doi: 10.5306/wjco.v15.i6.684

Current status of anaplastic thyroid carcinoma

Abrahams Ocanto, Lisselott Torres, Felipe Couñago

Abrahams Ocanto, Lisselott Torres, Felipe Couñago, Department of Radiation Oncology, San Francisco de Asís University Hospital, Genesis Care, Madrid 28002, Spain

Abrahams Ocanto, Lisselott Torres, Felipe Couñago, Department of Radiation Oncology, Vithas La Milagrosa University Hospital, Genesis Care, Madrid 28010, Spain

Author contributions: Ocanto A, Torres L and Couñago F contributed to this paper; Ocanto A, Torres L and Couñago F designed the overall concept and outline of the manuscript; Couñago F contributed to the discussion and design of the manuscript; Ocanto A, Torres L and Couñago F contributed to the writing, and editing the manuscript and review of literature.

Conflict-of-interest statement: The authors declare no conflicts of interest.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Abrahams Ocanto, MD, Doctor, Department of Radiation Oncology, San Francisco de Asís University Hospital, 28 Joaquín Costa St, Genesis Care, Madrid 28002, Spain. abrahams.ocanto@genesiscare.es

Received: January 11, 2024
Revised: April 21, 2024
Accepted: April 25, 2024
Published online: June 24, 2024
Processing time: 165 Days and 2.1 Hours

Core Tip

Core Tip: Anaplastic thyroid carcinoma is an entity with high mortality despite the combination of treatments, today molecular analysis opens the door to new drugs that impact survival in a positive way when used in a multimodal form.